Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros

Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Ann Clin Microbiol Antimicrob ; 22(1): 75, 2023 Aug 17.
Artículo en Inglés | MEDLINE | ID: mdl-37592268

RESUMEN

INTRODUCTION: Carbapenems (CR) have traditionally been the first line treatment for bacteremia caused by AmpC-producing Enterobacterales. However, CR have a high ecological impact, and carbapenem-resistant strains continue rising. Thus, other treatment alternatives like Piperacillin-Tazobactam (P-T) or Cefepime (CEF) and oral sequential therapy (OST) are being evaluated. METHODS: We conducted a retrospective, single-centre observational study. All adult patients with AmpC-producing Enterobacterales bacteremia were included. The primary endpoint was clinical success defined as a composite of clinical cure, 14-day survival, and no adverse events. We evaluated the evolution of patients in whom OST was performed. RESULTS: Seventy-seven patients were included, 22 patients in the CR group and 55 in the P-T/CEF group (37 patients received CEF and 18 P-T). The mean age of the patients was higher in the P-T/CEF group (71 years in CR group vs. 76 years in P-T/CEF group, p = 0.053). In the multivariate analysis, age ≥ 70 years (OR 0.08, 95% CI [0.007-0.966], p = 0.047) and a Charlson index ≥ 3 (OR 0.16, 95% CI [0.026-0.984], p = 0.048), were associated with a lower clinical success. Treatment with P-T/CEF was associated with higher clinical success (OR 7.75, 95% CI [1.273-47.223], p = 0.026). OST was performed in 47% of patients. This was related with a shorter in-hospital stay (OST 14 days [7-22] vs. non-OST 18 days [13-38], p = 0.005) without difference in recurrence (OST 3% vs. non-OST 5%, p = 0.999). CONCLUSIONS: Targeted treatment with P-T/CEF and OST could be safe and effective treatments for patients with AmpC-producing Enterobacterales bacteremia.


Asunto(s)
Bacteriemia , Sepsis , Adulto , Humanos , Anciano , Estudios Retrospectivos , Cefepima/uso terapéutico , Bacteriemia/tratamiento farmacológico , Carbapenémicos/uso terapéutico , Combinación Piperacilina y Tazobactam/uso terapéutico
2.
Eur J Clin Microbiol Infect Dis ; 41(12): 1399-1405, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36205803

RESUMEN

Carbapenem-resistant Enterobacterales (CRE) infections are a major health problem. Intestinal colonization is a key factor in developing infection. However, factors associated with persistent colonization by CRE are unknown. The aim of the study was to identify factors associated with persistent CRE gut colonization. This is a retrospective, single-centre, observational study of adult patients with CRE gut colonization between January 2015 and January 2020. Epidemiologic characteristics, comorbidities, infectious events, duration of hospitalization and antimicrobial treatment received in the follow-up period were collected. Colonization was defined as isolation in at least 2 rectal swab culture samples of CRE. Decolonization was defined as 3 negative rectal swab cultures or 2 negative cultures and a negative molecular test. A cohort of 86 patients with CRE gut colonization was selected: 44 patients with spontaneous decolonization (DC) and 42 patients with persistent colonization (PC). The mean follow-up period was 24 months (IQR 14-33) in the DC group vs. 25 months (IQR 16-36) in the PC group (p = 0.478). Patient characteristics were similar between both groups. Colonization by other MDR microorganisms was high (44 patients, 51%) and slightly more common in the PC group (PC 60% vs. DC 43%, p = 0.139). The use of ceftazidime-avibactam was more common among the PC group (PC 33% vs. DC 14%, p = 0.041). We observed a higher percentage of antimicrobial therapy in the previous 30 days (PC 68% vs. DC 57%, p = 0.371) and 90 days (PC 81% vs. DC 82%, p = 0.353) in the PC group. Multivariable analysis showed that patients that have received ceftazidime-avibactam therapy (OR 4.9 95% CI [1.45-16.39], p = 0.010), and those colonized by other MDR microorganisms (OR 2.5, 95% CI [0.96-6.25], p = 0.060) presented a higher risk of PC. Ceftazidime-avibactam use and colonization by other MDR microorganisms might be associated with CRE persistent gut colonization.


Asunto(s)
Infecciones por Enterobacteriaceae , Adulto , Humanos , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Infecciones por Enterobacteriaceae/epidemiología , Infecciones por Enterobacteriaceae/microbiología , Estudios Retrospectivos , Carbapenémicos/uso terapéutico , Antibacterianos/uso terapéutico , Factores de Riesgo
3.
Eur J Clin Microbiol Infect Dis ; 41(9): 1173-1182, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-35939239

RESUMEN

Therapeutic options for bacteremia caused by carbapenem-resistant Enterobacterales (CRE) OXA-48-type are limited. The objective of this study was to analyze clinical success of CAZ-AVI compared with best available therapy (BAT) in patients with Klebsiella pneumoniae carbapenemase-producing OXA-48-type bacteremia (CRKp-OXA-48). We conducted a retrospective, single-center observational study in adult patients with CRKp-OXA-48 between December 2015 and May 2019. We collected the patients' clinical and epidemiological characteristics, antibiotic treatment (CAZ-AVI vs. BAT), and evolution. Factors associated with clinical success were analyzed using binary logistic regression. The study included 76 patients with CRKp-OXA-48-type bacteremia 33 received CAZ-AVI and 43 BAT. CAZ-AVI was mainly used in monotherapy (91%). Clinical success was more common in patients < 70-year-old (OR 4.79, 95% CI [1.435-16.002], p = 0.011) and CAZ-AVI treatment (OR 6.69, 95% CI [1.68-26.604], p = 0.007). Kaplan-Meier survival curve of 14-day mortality showed a lower mortality in patients who received CAZ-AVI (log rank 0.013). However, CAZ-AVI did not achieve statistical difference in IPTW for 14- and 30-day mortality (aOR 0.1, 95% CI [0.02-1.22], p = 0.076 and aOR 1.7, 95% CI [0.48-5.98], p = 0.413, respectively). CAZ-AVI treatment might be associated with a greater clinical success in CRKp-OXA-48 bacteremia.


Asunto(s)
Bacteriemia , Enterobacteriaceae Resistentes a los Carbapenémicos , Adulto , Anciano , Antibacterianos/uso terapéutico , Compuestos de Azabiciclo , Bacteriemia/tratamiento farmacológico , Proteínas Bacterianas , Ceftazidima/uso terapéutico , Cefalosporinas , Combinación de Medicamentos , Humanos , Klebsiella pneumoniae , Pruebas de Sensibilidad Microbiana , Estudios Retrospectivos , beta-Lactamasas
4.
Anal Chim Acta ; 1065: 12-20, 2019 Aug 13.
Artículo en Inglés | MEDLINE | ID: mdl-31005144

RESUMEN

We are reporting an innovative building-block for the development of biosensors based on the non-covalent functionalization of multi-walled carbon nanotubes (MWCNTs) with avidin (MWCNTs-avidin). In this work, at variance with previous reports, avidin has the double role of simultaneously being the exfoliating agent of MWCNTs and the platform for anchoring different biotinylated biomolecules. The optimum dispersion was obtained by sonicating for 5.0 min 0.50 mgmL-1 MWCNTs with 1.00 mgmL-1 avidin solution prepared in 50:50 v/v ethanol/water. As proof-of-concept, we immobilized biotinylated horseradish peroxidase (b-HRP) at glassy carbon electrodes (GCE) modified with MWCNTs-avidin to develop a hydrogen peroxide biosensor using hydroquinone as redox mediator. Surface plasmon resonance, electrochemical impedance spectroscopy, cyclic voltammetry and amperometry demonstrated that, even after the partial denaturation of avidin due to the drastic conditions used to functionalize the MWCNTs, it preserves the biorecognition properties and efficiently interacts with biotinylated horseradish peroxidase (b-HRP). The analytical characteristics of the resulting hydrogen peroxide biosensor are the following: linear range between 1.0 × 10-6 M and 1.4 × 10-5 M, sensitivity of (1.37 ±â€¯0.04) x 105 µAM-1, detection limit of 24 nM and reproducibility of 2.9%. The sensor was challenged with different samples, a mouthwash solution, human blood serum and milk, with very good performance.


Asunto(s)
Avidina/química , Técnicas Biosensibles , Técnicas Electroquímicas , Peroxidasa de Rábano Silvestre/metabolismo , Peróxido de Hidrógeno/análisis , Nanotubos de Carbono/química , Animales , Espectroscopía Dieléctrica , Electrodos , Peroxidasa de Rábano Silvestre/química , Humanos , Leche/química , Resonancia por Plasmón de Superficie
5.
J Mater Chem B ; 3(18): 3870-3884, 2015 May 14.
Artículo en Inglés | MEDLINE | ID: mdl-32262860

RESUMEN

Peptide-based biomaterials are being studied actively in a variety of applications in materials science and biointerface engineering. Likewise, there has been ongoing exploration over the last few decades into the potential biological applications of carbon nanomaterials, motivated by their size, shape, structure and their unique physical and chemical properties. In recent years, the functionalization of carbon nanotubes and graphene has led to the preparation of bioactive carbon nanomaterials that are being used in biomedicine as structural elements and in gene therapy and biosensing. The present study proposes different strategies for the bonding of l-tyrosine and the homopolypeptide poly-l-tyrosine to graphene oxide nanoribbons (GONRs). The covalent attachment of l-tyrosine was undertaken by amidation of the α-amine group of tyrosine with the existing carboxylic groups in GONR and by means of esterification through phenol nucleophiles contained in their side chains. In both cases use was made of protective groups to address the functionalization with the desired reactive groups. The linking of GONRs to the PTyr was attempted according to two different strategies: either by ester bonding of commercial PTyr through its phenol side groups or by in situ ring-opening polymerization of an N-carboxyanhydride tyrosine derivative (NCA-Tyr) with Tyr-functionalized GONRs. These biofunctionalized nanomaterials were characterized by Raman and infrared spectroscopies, X-ray photoelectron spectroscopy, thermogravimetric analysis, transmission electron microscopy, fluorescence and electrochemical techniques. On the basis of their properties, prospects for the potential utilization of the prepared hybrid nanomaterials in different applications are also given.

6.
An Med Interna ; 15(7): 367-9, 1998 Jul.
Artículo en Español | MEDLINE | ID: mdl-9710987

RESUMEN

We had reviewed all the patients with Histiocytic Necrotizing Lymphadenitis (Kikuchi's disease) seen in a General Hospital during two years. Three of the six cases were young females who showed the same clinical symptoms: Fever and unilateral painful, lymphadenopathy, usually at the latero-cervical region. All patients have mild neutropenia and high levels of serum transaminases. The lymph node biopsy yielded the proper diagnostic in all cases. The course of disease was good, and all patients healed without treatment one to two month after the symptom started. To date, we have not recorded any relapse. Our finding are quite similar to the other cases published in the medical literature. The benign course of this disease, and the need for biopsy to get a correct diagnosis, can explain why this disease may be unrecognized in clinical practice.


Asunto(s)
Linfadenitis/patología , Adolescente , Adulto , Biopsia , Femenino , Estudios de Seguimiento , Histiocitos , Humanos , Ganglios Linfáticos/patología , Linfadenitis/diagnóstico , Cuello , Necrosis , Síndrome , Factores de Tiempo , Tomografía Computarizada por Rayos X
7.
Anal Chim Acta ; 805: 19-35, 2013 Dec 17.
Artículo en Inglés | MEDLINE | ID: mdl-24296140

RESUMEN

This review present a critical comparison of the electrochemical behavior and analytical performance of glassy carbon electrodes (GCE) modified with carbon nanotubes (CNTs) dispersed in different polymers: polyethylenimine (PEI), PEI functionalized with dopamine (PEI-Do), polyhistidine (Polyhis), polylysine (Polylys), glucose oxidase (GOx) and double stranded calf-thymus DNA (dsDNA). The comparison is focused on the analysis of the influence of the sonication time, solvent, polymer/CNT ratio, and nature of the polymer on the efficiency of the dispersions and on the electrochemical behavior of the resulting modified electrodes. The results allow to conclude that an adequate selection of the polymers makes possible not only an efficient dispersion of CNTs but also, and even more important, the building of successful analytical platforms for the detection of different bioanalytes like NADH, glucose, DNA and dopamine.


Asunto(s)
Técnicas Biosensibles , Técnicas Electroquímicas , Nanotubos de Carbono/química , Polímeros/química , Dopamina/análisis , Glucosa/análisis , Humanos
9.
Clin Infect Dis ; 27(5): 1130-3, 1998 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9827257

RESUMEN

The management of Candida albicans endophthalmitis in intravenous drug abusers (IVDAs) has yet to be established. Early vitrectomy was previously reported as a promising treatment for C. albicans endophthalmitis. In our series, C. albicans endophthalmitis was diagnosed for 15 IVDAs. Funduscopic examinations confirmed severe vitritis in 12 patients and chorioretinitis in three. Blood and vitreal cultures were positive for C. albicans for seven and eight patients, respectively. Patients with vitritis received antifungal therapy before and after vitrectomy. Amphotericin B or fluconazole therapy was given according to the physician's preference. Vitrectomy was defined as early if it was performed within 1 week after the diagnosis of vitritis. All seven patients who underwent early vitrectomy had a favorable response without complications. Two of three patients who underwent late vitrectomy developed blindness or scotoma. Blindness was also described in two patients with vitritis who did not undergo vitrectomy. Early vitrectomy preceded and followed by antifungal therapy seems to be appropriate management of vitritis in IVDAs.


Asunto(s)
Antifúngicos/uso terapéutico , Candidiasis/terapia , Endoftalmitis/terapia , Infecciones Fúngicas del Ojo/terapia , Dependencia de Heroína/complicaciones , Vitrectomía , Adulto , Anfotericina B/uso terapéutico , Ceguera/etiología , Candidiasis/complicaciones , Candidiasis/tratamiento farmacológico , Candidiasis/cirugía , Terapia Combinada , Endoftalmitis/complicaciones , Endoftalmitis/tratamiento farmacológico , Endoftalmitis/cirugía , Infecciones Fúngicas del Ojo/complicaciones , Infecciones Fúngicas del Ojo/tratamiento farmacológico , Infecciones Fúngicas del Ojo/cirugía , Femenino , Fluconazol/uso terapéutico , Humanos , Inyecciones Intravenosas , Masculino , Agudeza Visual
10.
Infection ; 27(2): 132-3, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10219646

RESUMEN

Granulomatous hepatitis associated with Coxiella burnetii acute infection has an adverse clinical course in some patients. Surprisingly, it does not respond to antibiotic but to steroids treatment. A hypersensitivity mechanism has been implicated. A case of granulomatous hepatitis complicating C. burnetii acute infection is reported, which was refractory to antibiotics but, as in four other cases previously reported, showed a complete response to steroids. This case was found to support findings that moderate doses of steroids can be useful in patients with granulomatous hepatitis complicating C. burnetii infection and showing no response to antibiotic treatment.


Asunto(s)
Antiinflamatorios/uso terapéutico , Granuloma/tratamiento farmacológico , Hepatitis/tratamiento farmacológico , Prednisona/uso terapéutico , Fiebre Q/tratamiento farmacológico , Enfermedad Aguda , Adulto , Antiinfecciosos/uso terapéutico , Ciprofloxacina/uso terapéutico , Doxiciclina/uso terapéutico , Quimioterapia Combinada , Granuloma/complicaciones , Hepatitis/complicaciones , Humanos , Masculino , Fiebre Q/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA